Abstract
The aim of this study was to evaluate the efficacy of the Contiform intravaginal device for stress incontinence after the addition of a fourth size. We offered the device to a cohort of 73 women with a main complaint of stress incontinence but no prolapse. Of the 73 women invited to participate, 65 enrolled, of whom 52 were fitted. Of these 52 women, 37 (71%) completed the study protocol. Outcome measures were the 24-h pad test, St George score, and quality of life tests. Urine loss on pad test was significantly reduced from a median 6.6 g (interquartile range [IQR] = 4.3–22.6) to 2.2 g (IQR = 0.5–8.2; P = 0.0016) after 4 weeks with significant benefit seen on the Incontinence Impact Questionnaire and Urinary Distress Inventory. The insertion technique was quickly learnt, and the device was well tolerated. The recently developed medium/large size of Contiform was used by 6/37 (16%) women.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Morris AR, Moore KH (2003) The Contiform incontinence device—efficacy and patient acceptability. Int Urogynecol J 14:412–417
Karantanis E, O’Sullivan R, Moore KH (2003) The 24-hour pad test in continent women and men: normal values and cyclical changes. Br J Obstet Gynaecol 110:567–571
Blackwell AL, Yoong W, Moore KH (2004) Criterion validity, test–retest reliability and sensitivity to change of the St George urinary incontinence score. BJU Int 93:331–335
Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178
Moore KH (2000) Conservative management for urinary incontinence. Ballieres Best Pract Res Clin Obstet Gynaecol 14:251–289
Acknowledgements
The authors wish to thank the late Dr. Nicholas Biswas, original designer of the device and of the fourth size, for the donation of a personal computer to the research staff of the unit.
Note:
Contiform does not currently have FDA approval, but is available from Contiform International EShop in Australia
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allen, W.A., Leek, H., Izurieta, A. et al. Update: the “Contiform” intravaginal device in four sizes for the treatment of stress incontinence. Int Urogynecol J 19, 757–761 (2008). https://doi.org/10.1007/s00192-007-0519-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-007-0519-1